Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas. (Q47287484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

Elisa Dora Bal De Kier Joffe

30 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Mirta Varela

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ana Morandi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

José Lastiri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Silvia Christiansen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

María G Pallotta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lydia Puricelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

113-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15218947%20AND%20SRC:MED&resulttype=core&format=json

Long-term survival in malignant glioma. Prognostic factors

30 December 2019

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications

1 reference

12 December 2020

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

1 reference

12 December 2020

Database of p53 gene somatic mutations in human tumors and cell lines

1 reference

12 December 2020

Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.

1 reference

12 December 2020

Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation

1 reference

12 December 2020

Subsets of glioblastoma multiforme defined by molecular genetic analysis

1 reference

12 December 2020

Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

1 reference

12 December 2020

Tumor surveillance via the ARF-p53 pathway.

1 reference

12 December 2020

p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.

1 reference

12 December 2020

mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line

1 reference

12 December 2020

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

1 reference

12 December 2020

A tiger behind many doors: multiple genetic pathways to malignant glioma

1 reference

12 December 2020

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

12 December 2020

The molecular and genetic basis of neurological tumours

1 reference

12 December 2020

p53 protein expression in central nervous system neoplasms

1 reference

12 December 2020

Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas

1 reference

12 December 2020

MDM2 and p53: a question of balance

1 reference

12 December 2020

p53 immunoreactivity in astrocytomas and its relationship to survival

1 reference

12 December 2020

Expression of p14ARF overcomes tumor resistance to p53.

1 reference

12 December 2020

Molecular biology of glioma tumorigenesis

1 reference

12 December 2020

p53 immunohistochemical positivity as a prognostic marker in intracranial tumours.

1 reference

12 December 2020

Immunohistochemical markers for prognosis of cerebral glioblastomas

1 reference

12 December 2020

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

1 reference

12 December 2020

Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors.

1 reference

12 December 2020

Influence of p53 mutations on prognosis of patients with glioblastoma.

1 reference

12 December 2020

The physiology of p16(INK4A)-mediated G1 proliferative arrest

1 reference

12 December 2020

The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.

1 reference

12 December 2020

Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.

1 reference

12 December 2020

Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors

1 reference

12 December 2020

Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma

1 reference

12 December 2020

CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas.

1 reference

12 December 2020

Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ.

1 reference

12 December 2020

Interaction between the retinoblastoma protein and the oncoprotein MDM2

1 reference

12 December 2020

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.

1 reference

12 December 2020

Survival rates for primary malignant brain tumours in Europe. EUROCARE Working Group

1 reference

12 December 2020

Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme

1 reference

12 December 2020